U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT06884267) titled 'Hyperkalemia Quality Improvement Program (HK-QIP) Study' on March 13.
Brief Summary: This is a prospective, multi-center, single-arm study to evaluate the impact of implementation of guideline determined medical therapy (GDMT) for quality control improvement in non-dialysis chronic kidney disease (CKD-ND) patients, as well as provide evidence for standard hyperkalemia management with RAASi optimization in China CKD-ND patients.
Study Start Date: May 21
Study Type: INTERVENTIONAL
Condition:
Hyperkalemia Patient With Non-Dialysis Chronic Kidney Disease
Intervention:
OTHER: standard hyperkalemia management implementation
The in...